5 insiders reported 13 Form 4 transactions for Ascendis Pharma A/S (ASND) over the past 18 months (most recent 2026-09-09). Recent activity: Bodenhoff Mads (SVP & PAO) Buy 3,000 shares, Bodenhoff Mads (SVP & PAO) Sell 3,000 shares, HOLTUG LARS (Director) Sell 236 shares, BIENAIME JEAN JACQUES (Director) Buy 1,100 shares, BIENAIME JEAN JACQUES (Director) Buy 900 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-09 | Bodenhoff Mads | SVP & PAO | Buy | 3,000 | $330,000 |
| 2026-09-09 | Bodenhoff Mads | SVP & PAO | Sell | 3,000 | $810,570 |
| 2026-09-03 | HOLTUG LARS | Director | Sell | 236 | $62,335 |
| 2026-08-18 | BIENAIME JEAN JACQUES | Director | Buy | 1,100 | $270,435 |
| 2026-08-18 | BIENAIME JEAN JACQUES | Director | Buy | 900 | $222,219 |
| 2026-06-02 | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | Buy | 100 | $21,900 |
| 2026-06-01 | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | Buy | 250 | $55,830 |
| 2026-06-01 | BIENAIME JEAN JACQUES | Director | Buy | 200 | $44,752 |
| 2026-06-01 | BIENAIME JEAN JACQUES | Director | Buy | 200 | $44,460 |
| 2026-06-01 | BIENAIME JEAN JACQUES | Director | Buy | 100 | $22,350 |
| 2026-05-27 | BIENAIME JEAN JACQUES | Director | Buy | 200 | $47,248 |
| 2026-05-27 | BIENAIME JEAN JACQUES | Director | Buy | 200 | $47,874 |
| 2026-05-12 | JENSEN FLEMMING STEEN | EVP & Product Supply and Quality | Sell | 19,460 | $4.6M |
来源：SEC Form 4 申报文件 · 截至 2026-09-09